Top News

RCP Diagnostics Licenses Technology



Phoenix, Arizona-based RCP Diagnostics announced this morning that it has licensed its protein marker, for use in a blood diagnostic test for breast cancer. RCP said that it has licensed its protein marker to fellow Arizona firm Biomarker Technologies, which is developing a blood test for identifying cancer based on biomarkers. Financial terms were not disclosed. The licensing covers Biomarker's use of RCP's marker only for the diagnosis of breast cancer.


 

Marketplace

 

 

Latest Headlines

Browse Issues